Figure 1.
CONSORT diagram showing the number of patients randomized, screened for FLT3 mutations, and treated with and without midostaurin in each arm. TKD, tyrosine kinase domain.
CONSORT diagram showing the number of patients randomized, screened for FLT3 mutations, and treated with and without midostaurin in each arm. TKD, tyrosine kinase domain.
